Mads Daugaard
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Recent advances in purpose-built 3D bioprinted cancer models for drug development.
Journal: Expert opinion on drug discovery
Published: March 31, 2026
Enhanced precision in cell culture analytics: leveraging artificial intelligence for unbiased and non-destructive assessment of cell growth and viability.
Journal: Cell death discovery
Published: September 19, 2025
Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.
Journal: Cell death & disease
Published: May 14, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.
Journal: medRxiv : the preprint server for health sciences
Published: May 09, 2025
Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities.
Journal: Molecular cancer research : MCR
Published: October 11, 2024
Corrigendum: Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms.
Journal: Genes & development
Published: August 20, 2024
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors.
Journal: EMBO molecular medicine
Published: May 31, 2024
Pulsed Photothermal Therapy of Solid Tumors as a Precondition for Immunotherapy.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: October 19, 2023
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.
Journal: Nature communications
Published: October 09, 2023
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer.
Journal: Nature communications
Published: July 20, 2023
Last Updated: 09/26/2026